pembrolizumab,nivolumab
bms,merck
['nivo', 'pembro']
 i also believe that os data of pembro/nivo is a matter of time. brillantly presented in eha the correlation between pfs and os in ghsg trials. why shouldnt it happen in r/r hl?
Hematologist in Sao Paulo, Brazil. 
Focus on Lymphomas and CLL